Hildebrand, D.; Böhringer, J.; Körner, E.; Chiriac, U.; Förmer, S.; Sähr, A.; Hoppe-Tichy, T.; Heeg, K.; Nurjadi, D.
Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model. Antibiotics 2022, 11, 581.
https://doi.org/10.3390/antibiotics11050581
AMA Style
Hildebrand D, Böhringer J, Körner E, Chiriac U, Förmer S, Sähr A, Hoppe-Tichy T, Heeg K, Nurjadi D.
Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model. Antibiotics. 2022; 11(5):581.
https://doi.org/10.3390/antibiotics11050581
Chicago/Turabian Style
Hildebrand, Dagmar, Jana Böhringer, Eva Körner, Ute Chiriac, Sandra Förmer, Aline Sähr, Torsten Hoppe-Tichy, Klaus Heeg, and Dennis Nurjadi.
2022. "Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model" Antibiotics 11, no. 5: 581.
https://doi.org/10.3390/antibiotics11050581
APA Style
Hildebrand, D., Böhringer, J., Körner, E., Chiriac, U., Förmer, S., Sähr, A., Hoppe-Tichy, T., Heeg, K., & Nurjadi, D.
(2022). Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model. Antibiotics, 11(5), 581.
https://doi.org/10.3390/antibiotics11050581
